Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?
Risk factors for cardiovascular disease such as hypertension and hyperlipidemia are associated with cognitive decline. However, there is still no clear evidence that the use of antihypertensive or lipid-lowering therapy can prevent or delay cognitive decline or development of dementia. To provide a...
Saved in:
Main Author: | Ze-Min Kuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2020/1484357 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
by: null Preeti, et al.
Published: (2024-01-01) -
Dynamics of endothelial function in patients with arterial hypertension with different cardiovascular risk against the background of antihypertensive therapy
by: N.O. Pertseva, et al.
Published: (2024-10-01) -
Targeting lipid metabolism of macrophages: A new strategy for tumor therapy
by: Nan Shao, et al.
Published: (2025-02-01) -
Effect of Tai Chi combined with music therapy on the cognitive function in older adult individuals with mild cognitive impairment
by: Chunhui Zhou
Published: (2025-01-01) -
Adherence to Antihypertensive Medications in Iranian Patients
by: Azin Behnood-Rod, et al.
Published: (2016-01-01)